John Wiernikowski

1.7k total citations
28 papers, 814 citations indexed

About

John Wiernikowski is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John Wiernikowski has authored 28 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John Wiernikowski's work include Childhood Cancer Survivors' Quality of Life (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Central Venous Catheters and Hemodialysis (4 papers). John Wiernikowski is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Central Venous Catheters and Hemodialysis (4 papers). John Wiernikowski collaborates with scholars based in Canada, United States and New Zealand. John Wiernikowski's co-authors include Lillian Sung, Ronald D. Barr, Colin E. Webber, Uma H. Athale, Marilyn Wright, David R. Freyer, Doojduen Villaluna, Brad H. Pollock, Beverly J. Lange and B P Bliss and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

John Wiernikowski

28 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Wiernikowski Canada 15 318 209 163 136 92 28 814
Giorgio Attinà Italy 21 288 0.9× 326 1.6× 120 0.7× 234 1.7× 22 0.2× 114 1.3k
Tal Schechter Canada 20 282 0.9× 561 2.7× 377 2.3× 135 1.0× 23 0.3× 122 1.4k
Etan Orgel United States 23 351 1.1× 610 2.9× 665 4.1× 123 0.9× 74 0.8× 68 1.5k
Mehmet Kantar Türkiye 16 109 0.3× 288 1.4× 175 1.1× 92 0.7× 6 0.1× 68 757
Claus Bistrup Denmark 21 83 0.3× 93 0.4× 149 0.9× 322 2.4× 26 0.3× 88 1.3k
Floor Abbink Netherlands 18 243 0.8× 172 0.8× 141 0.9× 92 0.7× 4 0.0× 37 724
Nicole Erickson Germany 11 329 1.0× 138 0.7× 215 1.3× 102 0.8× 6 0.1× 38 1.4k
Dora Liu Canada 3 107 0.3× 45 0.2× 46 0.3× 160 1.2× 11 0.1× 4 909
Nicholas M. Mark United States 10 139 0.4× 61 0.3× 166 1.0× 96 0.7× 6 0.1× 25 1.0k
Robert R. Riggio United States 21 48 0.2× 156 0.7× 364 2.2× 313 2.3× 28 0.3× 41 1.2k

Countries citing papers authored by John Wiernikowski

Since Specialization
Citations

This map shows the geographic impact of John Wiernikowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Wiernikowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Wiernikowski more than expected).

Fields of papers citing papers by John Wiernikowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Wiernikowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Wiernikowski. The network helps show where John Wiernikowski may publish in the future.

Co-authorship network of co-authors of John Wiernikowski

This figure shows the co-authorship network connecting the top 25 collaborators of John Wiernikowski. A scholar is included among the top collaborators of John Wiernikowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Wiernikowski. John Wiernikowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiernikowski, John, et al.. (2022). The triponderal mass index as a measure of adiposity in pediatric survivors of acute lymphoblastic leukemia: a cross-sectional study. Scientific Reports. 12(1). 1404–1404. 2 indexed citations
2.
Mustafa, Reem A., Carlos A. Cuello‐García, Meha Bhatt, et al.. (2021). GRADE notes: How to use GRADE when there is “no” evidence? A case study of the expert evidence approach. Journal of Clinical Epidemiology. 137. 231–235. 25 indexed citations
3.
Wiernikowski, John & M. Brooke Bernhardt. (2020). Review of nutritional status, body composition, and effects of antineoplastic drug disposition. Pediatric Blood & Cancer. 67(S3). 16 indexed citations
4.
MacDonald, Tamara, et al.. (2018). Safety and efficacy of nabilone for acute chemotherapy‐induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review. Pediatric Blood & Cancer. 65(12). e27374–e27374. 24 indexed citations
5.
MacDonald, David, et al.. (2017). A Canadian Perspective on the Subcutaneous Administration of Rituximab in Non-Hodgkin Lymphoma. Current Oncology. 24(1). 33–39. 12 indexed citations
6.
7.
Sung, Lillian, Paula D. Robinson, Nathaniel S. Treister, et al.. (2015). Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Supportive & Palliative Care. 7(1). 7–16. 80 indexed citations
8.
Turner, Robin, et al.. (2014). A Canadian Perspective on the Safe Administration of Bendamustine and the Prevention and Management of Adverse Events. Current Oncology. 21(1). 35–42. 2 indexed citations
9.
Wiernikowski, John & Stuart MacLeod. (2014). Regulatory and logistical issues influencing access to antineoplastic and supportive care medications for children with cancer in developing countries. Pediatric Blood & Cancer. 61(8). 1513–1517. 6 indexed citations
10.
Mehta, Parth S., et al.. (2013). Essential medicines for pediatric oncology in developing countries. Pediatric Blood & Cancer. 60(5). 889–891. 34 indexed citations
11.
Grunfeld, Eva, Jim A. Julian, Gregory R. Pond, et al.. (2011). Results of a multicenter randomized trial to evaluate a survivorship care plan for breast cancer survivors.. Journal of Clinical Oncology. 29(15_suppl). 9005–9005. 5 indexed citations
12.
Howell, Doris, Jonathan Sussman, John Wiernikowski, et al.. (2008). A mixed-method evaluation of nurse-led community-based supportive cancer care. Supportive Care in Cancer. 16(12). 1343–1352. 30 indexed citations
13.
Wiernikowski, John, et al.. (2007). Bisphosphonate Therapy for Reduced Bone Mineral Density During Treatment of Acute Lymphoblastic Leukemia in Childhood and Adolescence. Journal of Pediatric Hematology/Oncology. 29(9). 613–616. 33 indexed citations
14.
Wiernikowski, John & Uma H. Athale. (2005). Thromboembolic complications in children with cancer. Thrombosis Research. 118(1). 137–152. 28 indexed citations
15.
Barr, Ronald D., Alessandra Sala, John Wiernikowski, et al.. (2005). A formulary for pediatric oncology in developing countries. Pediatric Blood & Cancer. 44(5). 433–435. 11 indexed citations
16.
Barr, Ronald D., Chun Guo, John Wiernikowski, et al.. (2002). Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate. Medical and Pediatric Oncology. 39(1). 44–46. 36 indexed citations
17.
Coppes, Max J., Kung Wong Lau, Lewis C. Ingram, et al.. (1999). Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. Medical and Pediatric Oncology. 33(2). 99–105. 10 indexed citations
18.
Wiernikowski, John, et al.. (1991). Bacterial Colonization of Tunneled Right Atrial Catheters in Pediatric Oncology. Journal of Pediatric Hematology/Oncology. 13(2). 137–140. 7 indexed citations
19.
Wiernikowski, John, et al.. (1991). Evaluation of a Home Intravenous Antibiotic Program in Pediatric Oncology. Journal of Pediatric Hematology/Oncology. 13(2). 144–147. 39 indexed citations
20.
Mayhew, E., et al.. (1990). Free and Liposomal Doxorubicin Treatment of Intraperitoneal Colon 26 Tumor: Therapeutic and Pharmacologic Studies. PubMed. 6(4). 193–209. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giorgio Attinà Breakdown of academic impact, for papers by Tal Schechter Breakdown of academic impact, for papers by Etan Orgel Breakdown of academic impact, for papers by Mehmet Kantar Breakdown of academic impact, for papers by Claus Bistrup Breakdown of academic impact, for papers by Floor Abbink Breakdown of academic impact, for papers by Nicole Erickson Breakdown of academic impact, for papers by Dora Liu Breakdown of academic impact, for papers by Nicholas M. Mark Breakdown of academic impact, for papers by Robert R. Riggio
Rankless by CCL
2026